SCHEMBL7443680

SCHEMBL7443680

CCc1cccc(C(O)=S)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.47
TP53 P04637 2/20 0.46
KAT6A Q92794 2/20 0.45
SMYD3 Q9H7B4 1/20 0.42
CNR2 P34972 1/20 0.42
FOLH1 Q04609 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
PTGS2 P35354 1/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
TRPA1 O75762 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38652489 1.00 BCL2 (0.47) BCL2TP53KAT6ASMYD3CNR2
SCHEMBL28425373 0.84 TP53 (0.48) BCL2TP53KAT6ASMYD3CNR2
SCHEMBL38652541 0.84 KAT6A (0.48) KAT6ACNR2FOLH1CYP4F2CYP4A11
Thiobenzoic Acid SCHEMBL29067224 0.83 TP53 (0.64) TP53SMN1; SMN2GAA
SCHEMBL6895267 0.82 SMN1; SMN2 (0.59) BCL2KAT6ASMYD3CNR2SMN1; SMN2
SCHEMBL10937018 0.82 CNR2 (0.44) BCL2TP53KAT6ASMYD3CNR2
SCHEMBL38652580 0.81 LPL (0.47) CYP4F2CYP4A11
SCHEMBL11555316 0.80 LOXL2 (0.42) BCL2TP53KAT6ASMYD3CNR2
Hydrogen Peroxide SCHEMBL11520377 0.79 TP53 (0.63) BCL2TP53SMN1; SMN2PTGS2TRPA1
SCHEMBL46935 0.79 BCL2 (0.66) BCL2TP53FOLH1SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2699606-B1 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORP (JP) 2016-09-28 EP claimed
EP-2699606-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP Bridgestone Corporation (JP) 2014-02-26 EP claimed
US-20140018500-A1 Polymers Functionalized With A Carboxylic Or Thiocarboxylic Ester Containing A Silylated Amino Group BRIDGESTONE CORPORATION (JP) 2014-01-16 US claimed
WO-2012135451-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORPORATION (JP) 2012-10-04 WO claimed
CN-122010800-A A kind of substituted thiophenol is a process for the selective alkylation of 大连理工大学 2026-05-12 CN disclosed
CN-109476616-B Piperazinyl methanone NAAA inhibitors 加利福尼亚大学董事会 2023-10-13 CN disclosed
EP-2699606-B1 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORP (JP) 2016-09-28 EP disclosed
US-9403919-B2 Polymers functionalized with a carboxylic or thiocarboxylic ester containing a silylated amino group BRIDGESTONE CORPORATION (JP) 2016-08-02 US disclosed
EP-2699606-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP Bridgestone Corporation (JP) 2014-02-26 EP disclosed
US-20140018500-A1 Polymers Functionalized With A Carboxylic Or Thiocarboxylic Ester Containing A Silylated Amino Group BRIDGESTONE CORPORATION (JP) 2014-01-16 US disclosed
WO-2012135451-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORPORATION (JP) 2012-10-04 WO disclosed
EP-1096931-A2 USE OF (S) (-)-AMISULPRIDE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SCHIZOPHRENIA SANOFI-SYNTHELABO (FR) 2001-05-09 EP disclosed
US-6187807-B1 ADMINISTERING (S)(-)-AMISULPRIDE OR SALT THEREOF FREE OF THE (R)-(+)-STEREOISOMER, TO ELICIT ANTIPSYCHOTIC PROPERTIES IN A PATIENT SANOFI-SYNTHELABO (FR) 2001-02-13 US disclosed
US-6169094-B1 ANTIPSYCHOTIC AGENTS SANOFI-SYNTHELABO (FR) 2001-01-02 US disclosed
WO-2000003740-A2 USE OF (S) (-)-AMISULPRIDE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SCHIZOPHRENIA SANOFI-SYNTHELABO (FR) 2000-01-27 WO disclosed
US-4571437-A CATALYTIC HYDROGENATION REDUCTION AND REARRANGEMENT OF NITROBENZENE IN PRESENCE OF SULFUR COMPOUND MALLINCKRODT, INC. (US) 1986-02-18 US disclosed
US-4198428-A PESTICIDES, MICROBIOCIDES, MOLLUSCOCIDES BAYER AKTIENGESELLSCHAFT (DE) 1980-04-15 US disclosed
US-4118390-A 1-Thiazolyl-5-acyloxyimidazolidinones VELSICOL CHEMICAL COMPANY (US) 1978-10-03 US disclosed
US-4055569-A HERBICIDE VELSICOL CHEMICAL CORPORATION (US) 1977-10-25 US disclosed